Achieve Life Sciences Inc expected to post a loss of 16 cents a share - Earnings Preview

Achieve Life Sciences

03/08/2026 14:57

Achieve Life Sciences Inc ACHV.OQ ACHV.O is expected to  show no change in quarterly revenue when it reports  results on August 5 (estimated) for the period ending June 30 2026

​LSEG's mean analyst estimate for Achieve Life Sciences Inc is for a loss of 16 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Achieve Life Sciences Inc is $12.00, about 86.9% above its last closing price of $6.42
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.29
-0.31
-0.19
Beat
38.4
Dec. 31 2026
-0.29
-0.27
-0.28
Missed
-3.2
Sep. 30 2025
-0.24
-0.26
-0.28
Missed
-8.9​
Jun. 30 2025
-0.40
-0.36
-0.37
Missed
-1.6
​​Mar. 31 2025
-0.38
-0.36
-0.37
Missed
-1.8
Dec. 31 2024
-0.36
-0.32
-0.36
Missed
-12.5​
Sep. 30 2024
-0.28
-0.26
-0.36
Missed
-37.7
Jun. 30 2024
-0.23
-0.23
-0.25
Missed
-7.9
This summary was machine generated August 3 at 13:57 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)